OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30

$1.40−0.02 (-1.41%)

Close on Nov 12, 2026Market cap $73.47MP/E –Yield –

OKYO Pharma gross margin

Gross margin is gross profit as a percentage of revenue.

OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?